After setting January box office records, DreamWorks’ latest animated hit has made its way home. Dog Man, based on the beloved books from Dav Pilkey, is now available to purchase and rent from digital ...

Alec Baldwin is opening up about the “surreal” experience of misfiring a prop gun and fatally shooting cinematographer Halyna Hutchins on the 2021 set of “Rust,” and ...

"I Am Become Meme" is a quote spoken by Elon Musk during the Conservative Political Action Conference (CPAC) on February 20th ...

Mount Union fraternity Sigma Nu will host a nuggets fundraiser Wednesday to benefit an alumnus and his son, who both suffered ...

While romance and roses make for a lovely Valentine's Day gesture, filling your February 14 with both love and laughter is ...

At this point, everyone has probably seen the clip of a man exaggeratedly ripping his shirt and running in the rain. Montoya from Spain’s rendition of Temptation Island has been immortalized as a meme ...

Looking for clues for today's Connections answers? The Connections answers on February 8 for puzzle #608 is slightly easier ...

PHILADELPHIA -- Sick of swiping on dating apps, one Philadelphia man is putting himself out there in a very public way. In August 2024 Dave Kline, a 28-year-old data manager, rented a billboard in ...

For the quarter ended December 2024, Eli Lilly (LLY) reported revenue of $13.53 billion, up 44.7% over the same period last year. EPS came in at $5.32, compared to $2.49 in the year-ago quarter.

Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 116 trades. If we consider the specifics of each ...

Weight loss drugs are huge these days, and Eli Lilly (LLY) is leading the pack when it comes to these. However, today’s leader can become tomorrow’s laggard without continuous development ...

Eli Lilly LLY-N on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing investor agitation about signs of weakness in sales of the drugs.